Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. - Wikidata - wikimedia - TriplyDB

Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.

Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.

http://www.wikidata.org/entity/Q35452380

about

HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care Access to antiretroviral therapy during excess black-water flooding in central Thailand.Public health and international drug policy.In Vivo and in Vitro Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4+ T Cells.Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment.Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour HIV and Re-Incarceration: Time for a Comprehensive Approach.Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.Sexual HIV Risk Among Male Parolees and Their Female Partners: The Relate Project Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis.Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention.The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model.Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco.HIV Testing, HIV Positivity, and Linkage and Referral Services in Correctional Facilities in the United States, 2009-2013 Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.Correlates of retention in HIV care after release from jail: results from a multi-site study.Epidemiology of Infectious Disease-Related Death After Release from Prison, Washington State, United States, and Queensland, Australia: A Cohort Study Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.Cost analysis of enhancing linkages to HIV care following jail: a cost-effective intervention Condom use and incarceration among STI clinic attendees in the Deep South.The feasibility of implementing the HIV seek, test, and treat strategy in jails.A Randomized Controlled Trial of POWER: An Internet-Based HIV Prevention Intervention for Black Bisexual Men.High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada.Long Acting Injectable Anti-Retroviral Therapy: An Opportunity to Improve HIV Treatment and Reduce HIV Transmission among Persons being Released from Prison Facilities.Developing a Patient Navigation Program to Improve Engagement in HIV Medical Care and Viral Suppression: A Demonstration Project Protocol.Understanding Determinants of Racial and Ethnic Disparities in Viral Load Suppression.Jails, HIV testing, and linkage to care services: an overview of the EnhanceLink initiative.Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release.Medication use and knowledge in a sample of Indigenous and non-Indigenous prisoners.Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users: A Latent Class Analysis.Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study.Connecting Corrections and HIV Care: Building a Care Coordination Program for Recently Incarcerated Persons Living with HIV in Virginia.Commentary on Des Jarlais et al. (2012): are ethnic disparities in drug policy-related harms relevant to the addiction medicine community?HIV and Viral Hepatitis Among Imprisoned Key Populations.Risk behaviors and HIV care continuum outcomes among criminal justice-involved HIV-infected transgender women and cisgender men: Data from the Seek, Test, Treat, and Retain Harmonization Initiative.Jail, an unappreciated medical home: Assessing the feasibility of a strengths-based case management intervention to improve the care retention of HIV-infected persons once released from jail.

P2860

Q27014885-70C17084-7EFB-43D0-87E6-EC88105DE0B4 Q30223352-8819EB30-0DFA-430F-9F31-0D9030A634D4 Q30377895-A56D1A4F-8B03-49AA-8AF3-A641C596F7C4 Q30398955-4DD1141C-5AA3-4F95-8D40-AB6BFF12D0DD Q33640322-9703F2F8-38F4-472A-87F2-85E9CA2F85BB Q33725810-40F372EC-6459-455A-9901-E2A65338E5E9 Q34105570-DB77CB02-62F1-42D1-88CE-B2CFE7CD2CBC Q34653421-25154271-6A7D-419D-B8C9-804ED3A7FB98 Q34997577-9AE41C76-652C-4205-AAAE-98ED8146CCBE Q35021567-2329778A-7F95-419E-A22E-85BB5CF9BD3F Q35056683-820A4FA9-0F49-4FA1-B6AC-621F1284B234 Q35194961-AE85CC0A-8524-4147-849D-5436B8D2858A Q35532871-3C3E87C7-8B5F-44BE-A0E7-4462AD6158ED Q36293125-EB8106F5-73C4-48AE-98CA-CD540530ADE6 Q36636547-9050DB8D-8CA3-4CF2-A9D2-F74FB9092AA4 Q36853880-EEDC73A3-72A1-4FBF-ACB4-5143ADEA27A0 Q37022021-F36A536C-9096-431B-816D-BF094274991C Q37075726-EB4419C9-4400-4325-B253-5A906F4A8128 Q37227942-A07EDA0F-6DF4-48D2-A89D-0018336D2A0E Q37251571-ABEEDC87-164F-4B49-8687-ECC085F6D9DE Q37254854-18C3DCA3-9575-4981-B955-28AD74F2AF27 Q37701070-A19083EA-BBD9-4E00-96CD-5907BD857285 Q38880257-0E6FD7B2-37CF-43A3-8BFE-33519DA2564E Q38881551-3C400E9A-EFB9-45CF-B504-A7386B1C0D79 Q40197333-82885313-0C6A-40B9-B88B-7950243D1F01 Q40297229-1C652563-D127-4FC4-BBB4-57692047BA75 Q40581238-C53A0B52-BBE7-4D9B-90E6-88D2735605FD Q42288741-3F4E0463-BFF4-4285-A51C-06CFC36C53A1 Q43617340-4C3CCB86-5761-44B9-A6FB-C4B381FF91F6 Q45364134-32041AE9-8D5B-434B-B4A1-704BB4DFB6AD Q47203184-BDAC09C7-DEC8-492C-964D-39857C29F846 Q47389289-64422117-9F52-41F4-8FA6-F55E96691DC1 Q49719130-C53E47BA-4186-4165-B43F-6B5851013E50 Q52301805-91064BCA-8B33-4CD4-A60F-2128DFE56BF4 Q53403318-A597686F-D462-4C92-98CC-61799E69EA7D Q54202940-C47D7720-EB5B-4523-BFB1-FEAAD6B725FE Q54245009-25A6CAE7-A650-477B-A4B8-96488CC2B3B0

P2860

Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy.

http://www.wikidata.org/entity/Q35452380

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Incarceration predicts virolog ...... eiving antiretroviral therapy.

@ast

Incarceration predicts virolog ...... eiving antiretroviral therapy.

@en

type

label

Incarceration predicts virolog ...... eiving antiretroviral therapy.

@ast

Incarceration predicts virolog ...... eiving antiretroviral therapy.

@en

prefLabel

Incarceration predicts virolog ...... eiving antiretroviral therapy.

@ast

Incarceration predicts virolog ...... eiving antiretroviral therapy.

@en

P1433

Q35452380-1BE10B3D-9070-4AAA-9E90-C64439E74B9D

P1476

Q35452380-13A9D56C-69E7-46B7-A254-77A89CCD185B

P2093

Q35452380-17EB28EA-5B19-4560-849A-AFBC8226A3F4

Q35452380-38F30618-C2E7-4715-B334-0114DD467685

Q35452380-68AC848E-E28E-4EE1-A95D-8C6628471733

Q35452380-EF260109-A4EB-43F5-9BB7-3387756B57A9

P2860

Q35452380-0075EF65-D885-400E-8270-1177D52E9D1F

Q35452380-014B3ABE-7C52-4DA5-BE3E-377A6038C60A

Q35452380-0B5A2B18-215E-4196-9A50-2A8EE6DA42BC

Q35452380-0D5A9A77-803D-4DC8-9275-726DEDCA5D40

Q35452380-2837AF28-9506-4896-A8F2-31EEF4BFFE03

Q35452380-288E17A3-B0D6-4B80-9808-D676BB22C059

Q35452380-294D7CA9-6EA2-43D5-A237-0396EDAD6A7B

Q35452380-2D7A801B-ABDD-4F7C-9243-CB2F3AB36FE0

Q35452380-47559BE4-ECBD-4B05-935A-CA4FF6056302

Q35452380-4AE49CC7-86A3-470C-8E20-82C614E2FDA0

P304

Q35452380-59F7A804-AADD-43A7-B31C-5AA742A55993

P31

Q35452380-D6747C6C-0006-41C3-B80D-1D20E39358F7

P356

Q35452380-465D97C6-7BA5-4667-A786-76413A6498F9

P407

Q35452380-554D6C89-9107-4E9F-8462-AD7FEB0B782E

P433

Q35452380-DA1E1E97-AC09-47DD-8C33-4DD6F12E56E0

P478

Q35452380-C4BAB5BB-A448-4B57-B3A2-B1C85BA90E4B

P50

Q35452380-75E72D1E-D938-47D3-821A-4D1DD2135788

P577

Q35452380-605818CF-6D84-403F-A96E-7B8CB3453D58

P5875

Q35452380-84D34B31-4F94-41B6-AE29-4B0B976FC836

P698

Q35452380-1520DEDB-8F5D-4872-A2B3-F15B2E058C79

P921

Q35452380-2AC6D473-964E-4D8F-B1CC-309ED0149B6A

Q35452380-65458249-30FE-45BD-A39E-613F7F1E6D3D

P932

Q35452380-A9FA2C2D-FA75-4DB6-9A52-0E4EDFEEEB7C

P356

P1433

Clinical Infectious Diseases

P1476

Incarceration predicts virolog ...... eiving antiretroviral therapy.

@en

P2093

Douglas R Richesson

http://www.w3.org/2001/XMLSchema#string

Gregory D Kirk

http://www.w3.org/2001/XMLSchema#string

Noya Galai

http://www.w3.org/2001/XMLSchema#string

Shruti H Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis.

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.

Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial

Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection

Accessing antiretroviral therapy following release from prison.

Trust and the acceptance of and adherence to antiretroviral therapy.

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.

The survival benefits of AIDS treatment in the United States.

P304

725-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIR491

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Ryan P. Westergaard

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51618028

http://www.w3.org/2001/XMLSchema#string

P698

21890777

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3202322

http://www.w3.org/2001/XMLSchema#string